TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
NVCT

Nuvectis Pharma Inc

Healthcare · Biotechnology

20.20$ -6.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Nuvectis Pharma Inc (NVCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 22 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NVCT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
22 19 20 18 17 19 30 27 36 32 25 22
22 19 20 18 17 19 30 27 36 32 25 22
22 19 19 18 17 19 30 27 35 32 25 22
22 19 19 18 17 19 30 27 35 32 25 22
5.6 7.0 5.7 5.8 6.3 8.9 9.2 10 12 13 11 13
5.6 7.0 5.7 5.8 6.3 8.9 9.2 10 12 13 11 13
3.5 2.8 1.8 1.8 2.3 2.5 3.0 5.0 6.4 6.3 4.7 5.2
17 12 14 13 11 9.7 21 17 24 18 14 9.1
-48 -54 -58 -63 -67 -73 -79 -85 -92 -100 -106 -113
16 17 17 17 17 19 20 21 23 22 23 23

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?